ライフサイエンスコーパス: insulin sensitizer

1 , a lipocalin superfamily member, is a novel insulin sensitizer.

2 SH2B1 is an endogenous insulin sensitizer.

3 ns for all causes did not differ with either insulin sensitizer.

4 bolic parameters showed that R-1 and S-1 are insulin sensitizers.

5 ption factors to dial out adverse effects of insulin sensitizers.

6 ma-dependent effects transcend their role as insulin sensitizers.

7 etagogues, and thiazolidinediones, which are insulin sensitizers.

8 g a TZD and 4,700 (65.8%) were not receiving insulin sensitizers.

9 o PTP1B can act as both insulin mimetics and insulin sensitizers.

10 per se and are influenced by the actions of insulin sensitizers.

11 rget of the thiazolidinedione (TZD) class of insulin sensitizers.

12 ng adipose-derived factor that, unlike other insulin sensitizers, acts directly on the insulin recept

13 olidinediones (TZDs), a widely used class of insulin sensitizers, acutely and specifically inhibit mi

14 uction of adiponectin, an adipocyte-specific insulin sensitizer and anti-inflammatory agent.

15 g of the thiazolidinedione class, acts as an insulin sensitizer and improves hyperglycemia.

16 amma (PPAR-gamma) agonist, rosiglitazone, an insulin sensitizer and mitochondrial activator, improves

17 as thiazolidinediones (TZDs), are effective insulin sensitizers and anti-inflammatory agents, but th

18 NIDDM) and obesity, RXR agonists function as insulin sensitizers and can decrease hyperglycaemia, hyp

19 able by reduction of insulin resistance with insulin sensitizers and stringent control of hyperglycem

20 ds (thiazolidinediones (TZDs)) are important insulin sensitizers and were recently shown to indirectl

21 new class of oral antidiabetic agents, are "insulin sensitizers" and exert direct effects on the mec

22 Adiponectin functions as an insulin sensitizer, and yet the underlying molecular mec

23 festyle modification, lipid-lowering agents, insulin sensitizers, and treatments to reverse endocrine

24 Clomiphene and insulin sensitizers are used alone and in combination to

25 IGF-I is recognized as an insulin sensitizer at the liver and muscle, while recent

26 igned to determine whether they (or similar "insulin sensitizers") decrease cardiovascular events in

27 Ertiprotafib belongs to a novel class of insulin sensitizers developed for treatment of type 2 di

28 The advent of insulin sensitizers enables clinicians to target treatme

29 the impaired glucose-tolerant subjects with insulin sensitizers for 10 weeks, pioglitazone (but not

30 sm and is the molecular target of a class of insulin sensitizers, genetic variants that alter Pparg g

31 sed by inflammatory signals but increased by insulin sensitizer in cultured adipocytes.

32 t RXR-selective agonists (e.g., 3 and 4) are insulin sensitizers in rodent models of non-insulin-depe

33 compounds that serve as insulin mimetics or insulin sensitizers in skeletal muscle may be effective

34 cological PPAR-gamma ligands, widely used as insulin sensitizers in the treatment of type-2 diabetes

35 lly restored after the administration of the insulin sensitizer metformin.

36 ifestyle changes (weight loss and exercise), insulin sensitizers (metformin, troglitazone), angiotens

37 d to determine the effects of treatment with insulin sensitizers on lipolysis, we measured palmitate

38 er 2 (SGLT2) inhibitor dapagliflozin and the insulin sensitizer pioglitazone.

39 ed with decreased insulin sensitivity and if insulin sensitizers play a role in prolonging islet graf

40 ARgamma), the molecular target of a class of insulin sensitizers, regulates adipocyte differentiation

41 Insulin sensitizers reverse phosphoinhibition of GIV and

42 er liver and kidney transplantation with the insulin sensitizer rosiglitazone (ROSI).

43 on in 3T3-L1 adipocytes is stimulated by the insulin sensitizer rosiglitazone and inhibited by the in

44 atherosclerosis, whereas treatment with the insulin sensitizer rosiglitazone attenuated both metabol

45 Furthermore, the insulin sensitizer rosiglitazone caused striking changes

46 The insulin sensitizer rosiglitazone improved insulin-stimul

47 termined the effect of the thiazolidinedione insulin sensitizer rosiglitazone on these proteins.

48 atment of insulin-resistant animals with the insulin sensitizer rosiglitazone restores vessel wall CR

49 enhanced by prior treatment of mice with the insulin sensitizer rosiglitazone.

50 ated with the Sglt inhibitor phloridzin, the insulin-sensitizer rosiglitazone, or insulin.

51 Rosiglitazone, a well known insulin sensitizer, stimulates adipocyte differentiation

52 adiponectin as an important adipose-derived insulin sensitizer that enhances fatty acid oxidation an

53 Our results demonstrate that MTZ acts as an insulin sensitizer that suppresses hepatic glucose produ

54 Thiazolidinediones (TZDs) are potent insulin sensitizers that act through the nuclear recepto

55 Thiazolidinediones are insulin sensitizers that activate the nuclear receptor P

56 After a prolonged fast, FGF21 acts as an insulin sensitizer to overcome the peripheral insulin re

57 t that FGF21 functions physiologically as an insulin sensitizer under conditions of acute refeeding a

58 Thiazolidinediones (TZDs) are insulin sensitizers used to treat patients with insulin

59 tin is an adipose tissue-secreted endogenous insulin sensitizer, which plays a key role as a mediator

60 Rexinoids represent a novel class of insulin sensitizers with potential applications in the t

61 rn regulate SREBP processing and thus couple insulin sensitizers with the regulation of lipid homeost